Schedule 13G ownership disclosure
ReShape Lifesciences Inc.
Common Stock, $0.001 par value per share · CUSIP: 76090R408
Event date: 2025-08-14
- Filing-level shares
- 7,862.00
- Percent of class
- 0.33%
- L1 Capital Global Opportunities Master Fund, Ltd.
Shares: 7,862.00 · Class: 0.33%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001079973-25-001309
- Form type
- SCHEDULE 13G/A
- Filer
- L1 Capital Global Opportunities Master Fund, Ltd.
- CIK
- CIK 1702202
- Filed
- Aug 14, 2025
- Reporting period
- Aug 14, 2025
- Description
- Schedule 13G beneficial ownership